Acute kidney injury secondary to severe delayed haemolysis in intravenous artesunate use for severe malaria.
BMJ Case Rep
; 14(1)2021 Jan 26.
Article
em En
| MEDLINE
| ID: mdl-33500299
ABSTRACT
The use of artemisinin derivatives has been recommended by the WHO guidelines in malaria treatment largely due to its rapid parasite clearance and safety profile. This case report details the development of delayed haemolysis and subsequent severe acute kidney injury (AKI) 13 days after commencing intravenous artesunate treatment for malaria in an Australian returned traveller. Delayed haemolysis may be an under-recognised complication following artesunate use and if severe, can be complicated by AKI. Therefore, close patient follow-up following treatment is required to ensure prompt recognition of this phenomenon.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Malária Falciparum
/
Injúria Renal Aguda
/
Artesunato
/
Anemia Hemolítica
/
Antimaláricos
Tipo de estudo:
Guideline
Limite:
Humans
/
Male
/
Middle aged
País/Região como assunto:
Oceania
Idioma:
En
Revista:
BMJ Case Rep
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Austrália